$99 million medical education and research facility opened
Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. have announced that they received approval from the European Commission to proceed with Teva’s acquisition of Barr. In connection with this approval, Teva and Barr are required to divest certain formulations of 17 generic drugs in certain specific countries with respect to which they have a product
Full Post: Teva and Barr receive European approval for acquisition
NSW Minister for Health John Della Bosca and Vice-Chancellor and Principal Dr Michael Spence have officially opened the University of Sydney’s new $99 million Kolling Building at Royal North Shore Hospital, providing a new purpose-built facility for medical researchers and clinical educators.
The ultra-modern building, jointly funded by the University of Sydney and NSW Health, includes seven floors for medical research and new facilities for educating the doctors, nurses and health professionals of the future.
“The Kolling Building is a significant milestone in our commitment to rebuild and revitalise the Royal North Shore Hospital site, and its completion marks the start of a new era in clinical research and education,” Mr Della Bosca said.
“This project also demonstrates the capacity of State Government to partner successfully with other institutions, in this case with the University of Sydney, to deliver enhanced facilities that benefit the community.”
Royal North Shore Hospital is renowned for its ‘bench to bedside’ research philosophy, where staff members are engaged in practical research that can be applied to patient care in areas such as cancer, pain management, diabetes and perinatal medicine.
“Opening of the Kolling Building marks a significant new phase of cooperation between North Sydney Health and the University of Sydney,” said Vice-Chancellor and Principal Dr Michael Spence.
“It is absolutely essential that research in this area is multidisciplinary and that it can be successfully taken from bench to bedside. This world class facility provides the ideal environment to achieve this,” he said
The Kolling Building is part of the $950 million redevelopment of Royal North Shore Hospital and community health facility which will be completed by 2013.
The Kolling Building, named in recognition of the Kolling Institute of Medical Research, has its own architectural identity and discrete presence on site.A particularly advanced feature or the building is the sophisticated IT and audiovisual installation, allowing for videoconferencing in most of the large teaching venues.
The building is also designed to provide above-ground connection to clinical treatment areas of the future acute hospital with a bridge link on level 5. A direct connection to the new main hospital building will allow easy flow from the acute care area to the research area for the many staff members engaged in active clinical research.
A team of researchers from the University of Sydney has developed an innovative new method to analyse digital photographs of faces in order to determine an individual’s risk of developing Obstructive Sleep Apnoea (OSA). In conjunction with the Royal North Shore Hospital and the Woolcock Institute of Medical Research, Professor Peter Cistulli and Dr Richard
Full Post: Researchers analyse photographs of faces to determine risk of developing sleep disorder
The University of Sydney is embarking on one of its largest ever recruitment drives in the wake of recent federal funding for an international centre of expertise in obesity, diabetes and cardiovascular disease. The $385 million biomedical centre, called the Centre for Obesity, Diabetes and Cardiovascular Disease,will house close to 100 research groups, enabling
Full Post: Obesity centre behind major staff expansion
Up to 150,000 people suffering from severe asthma in the UK could benefit from taking antifungal medication already available from pharmacists, new research has found. University of Manchester scientists found that pills used to treat everyday fungal infections greatly improved symptoms of asthma in those patients that had an allergic reaction to one or more
Full Post: Antifungal medication could provide asthma relief for 150,000 UK sufferers
A new £1m clinical research facility dedicated to tackling liver disease, the fifth most common cause of death in the UK, opens today at Imperial College London. Liver disease death rates are rising in the UK, in contrast to other common diseases such as heart disease and cancer, and the new Robert Hesketh Hepatology Clinical
Full Post: Liver disease tackled with dedicated unit at Imperial College London
Rich Glynn, a straight-talking entrepreneur from South Dakota, doesn’t mince words when explaining why a partnership between his fledgling goose operation and the University of North Dakota is a match made in heaven. “Had it not been for UND and the support of that University, we would never be where we are now,” he said.
Full Post: Biotech venture seeks West Nile virus treatment from antibodies in geese